• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on the article by Toorop et al.: "The relationship between DOAC levels and clinical outcomes: The measures tell the tale".

作者信息

Brunetti Enrico, Bo Mario

机构信息

Section of Geriatrics, A.O.U. Città della Salute e della Scienza, Molinette, Department of Medical Sciences, University of Turin, Turin, Italy.

出版信息

J Thromb Haemost. 2021 Apr;19(4):1134-1136. doi: 10.1111/jth.15245.

DOI:10.1111/jth.15245
PMID:33792174
Abstract
摘要

相似文献

1
Comment on the article by Toorop et al.: "The relationship between DOAC levels and clinical outcomes: The measures tell the tale".对图罗普等人文章的评论：“直接口服抗凝剂水平与临床结局的关系：指标说明一切”
J Thromb Haemost. 2021 Apr;19(4):1134-1136. doi: 10.1111/jth.15245.
2
Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study.心房颤动患者发生栓塞性卒中时的直接口服抗凝剂血浆水平：一项前瞻性多中心初步研究。
Eur J Clin Pharmacol. 2022 Apr;78(4):557-564. doi: 10.1007/s00228-022-03280-8. Epub 2022 Jan 22.
3
Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.持续性直接口服抗凝药物治疗患者行导管消融房颤时左心房血栓及自发性超声对比增强：达比加群、利伐沙班和阿哌沙班的比较。
Heart Rhythm. 2018 Apr;15(4):496-502. doi: 10.1016/j.hrthm.2017.12.005.
4
Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database.英国非瓣膜性心房颤动（NVAF）患者的直接口服抗凝剂（DOAC）剂量：一项使用CPRD Gold数据库的回顾性队列研究
Adv Ther. 2023 Feb;40(2):504-520. doi: 10.1007/s12325-022-02368-y. Epub 2022 Nov 18.
5
Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population-based cohort study.直接口服抗凝剂或华法林治疗与房颤患者新发糖尿病风险：一项基于人群的队列研究。
Cardiovasc Diabetol. 2021 Mar 25;20(1):71. doi: 10.1186/s12933-021-01263-0.
6
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.新型直接口服抗凝剂（DOACs），即阿哌沙班、达比加群和利伐沙班相关并发症的紧急处理建议。
Clin Res Cardiol. 2013 Jun;102(6):399-412. doi: 10.1007/s00392-013-0560-7. Epub 2013 May 14.
7
Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism.直接口服抗凝剂对伴有心房颤动和静脉血栓栓塞症患者凝血酶生成和纤维蛋白溶解的影响差异。
Blood Transfus. 2022 Nov;20(6):505-515. doi: 10.2450/2021.0153-21. Epub 2021 Nov 11.
8
Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.比较 CMS 医疗保险人群中老年非瓣膜性心房颤动患者使用直接口服抗凝剂与华法林的临床结局。
J Thromb Thrombolysis. 2019 Aug;48(2):240-249. doi: 10.1007/s11239-019-01838-5.
9
Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States.美国使用直接口服抗凝剂治疗非瓣膜性心房颤动患者的药物转换和停药率比较。
Adv Ther. 2019 Jan;36(1):162-174. doi: 10.1007/s12325-018-0840-8. Epub 2018 Nov 29.
10
Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.在标签外剂量下使用直接口服抗凝剂的房颤患者的特征和结局。
BMC Cardiovasc Disord. 2020 Feb 3;20(1):42. doi: 10.1186/s12872-020-01340-4.

引用本文的文献

1
The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization.DOAC 检测背后的误区：来自不同监管机构的说明书分析及实现统一化的呼吁
J Thromb Haemost. 2022 Nov;20(11):2494-2506. doi: 10.1111/jth.15884. Epub 2022 Oct 13.